CONSOLIDATED STATEMENTS OF INCOME - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Revenue
Total revenue	$ 687,180	$ 560,618	$ 519,908
Operating expenses
Cost of services, excluding depreciation and amortization	539,211	467,805	361,132
General and administrative expenses	49,116	41,482	43,354
Depreciation and amortization	18,350	18,280	19,303
Provision for doubtful accounts	0	(1,363)	3,888
Impairment of goodwill and intangible assets	0	1,994	3,799
Total expenses	606,677	528,198	431,476
Income from operations	80,503	32,420	88,432
Other (expense) income
Income (loss) from equity method investments	3,694	(6,901)	(8,125)
Interest expense	(9,499)	(4,733)	(561)
Interest income	2,813	2,024	1,259
Gain on sale of equity method investment	99,839	0	0
Other income	1,077	3,030	1,622
Total other income (expense), net	97,924	(6,580)	(5,805)
Income before provision for income taxes	178,427	25,840	82,627
Provision for income taxes	56,107	8,167	22,360
Net income	122,320	17,673	60,267
Net income attributable to noncontrolling interests	84,454	3,557	49,432
Net income attributable to Apollo Medical Holdings, Inc.	$ 37,866	$ 14,116	$ 10,835
Earnings per share – basic (in dollars per share)	$ 1.04	$ 0.41	$ 0.33
Earnings per share – diluted (in dollars per share)	$ 1.01	$ 0.39	$ 0.29
Weighted average shares of common stock outstanding – basic (in shares)	36,527,672	34,708,429	32,893,940
Weighted average shares of common stock outstanding - diluted (in shares)	37,448,430	36,403,279	37,914,886
Capitation, net
Revenue
Total revenue	$ 557,326	$ 454,168	$ 344,307
Risk pool settlements and incentives
Revenue
Total revenue	77,367	51,098	100,928
Management fee income
Revenue
Total revenue	34,850	34,668	49,743
Fee-for-service, net
Revenue
Total revenue	12,683	15,475	19,704
Other income
Revenue
Total revenue	$ 4,954	$ 5,209	$ 5,226